As you may already know, this is related to resveratrol, the chief medical excuse for drinking red wine. Resveratrol is a sirtuin modulator. Sinclair is one of the early researchers in this area. For some reason, he initially started collaborating with BIOMOL, a privately held trickle company in PA. Another player in this space is Elixir, also private, which about a year ago announced the discovery of potent SirT1 inhibitors. Clearly, Sirtris is a bit farther along, but I do not know anything about the IP situation. elixir claims to have some, but it's not like I've looked at any of it. I would guess all those high powered VCs checked that out, though.
Cheers, Tuck |
